Loading insider details...
Beta
Latest Form 4 (Mar 16, 2026): Sale of 5,369 SUPN shares, $271.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sale | 5,369 | $271.7K |
| Feb 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 4,475 | n/a |
| Feb 20, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 2,989 | n/a |
| Jan 12, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 15,000 | $194.7K |
| Oct 7, 2025 | scPharmaceuticals Inc. (SCPH) | Disposition to Issuer | 30,000 | n/a |
| Aug 18, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sale | 7,457 | $315.1K |
| Jun 5, 2025 | scPharmaceuticals Inc. (SCPH) | Grant/Award | 30,000 | n/a |
| Feb 24, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 5,369 | n/a |
| Feb 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 7,296 | n/a |
| Jan 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 20,000 | $182.6K |